Prophase Labs Inc (PRPH)
0.3396 -0.0107 (-3.05%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 0.3305 -0.0091 (-) 18:33 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | PRPH | VVOS | TXMD | ||
Company | Prophase Labs Inc | Vivos Therapeutics Inc | Therapeuticsmd Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.3500 | 2.70 | 1.1600 | ||
High | 0.3551 | 2.74 | 1.2400 | ||
Low | 0.3212 | 2.55 | 1.1600 | ||
Last | 0.3396 | 2.64 | 1.2300 | ||
Change | -0.0107 | -0.04 | +0.0100 | ||
% Change | -3.05% | -1.49% | +0.82% | ||
Volume | 338,400 | 35,500 | 49,000 | ||
20-Day Average Volume | 2,182,525 | 90,140 | 35,965 | ||
Previous Close | 0.3503 | 2.68 | 1.2200 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.3167 | 2.42 | 1.0187 | ||
20-Day Raw Stochastic | 39.87% | 72.53% | 97.50% | ||
20-Day Relative Strength | 47.45% | 45.85% | 63.85% | ||
Weighted Alpha | -82.52 | -17.06 | -33.40 | ||
Today's Opinion | 88% Sell | 72% Sell | 8% Sell | ||
Previous Opinion | 88% Sell | 72% Sell | 8% Sell | ||
Last Month's Opinion | 56% Sell | 40% Sell | 64% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.97% since 04/22/25 | +14.78% since 04/22/25 | +10.81% since 04/22/25 | ||
Low | 0.3212 on 04/29/25 | 2.35 on 04/23/25 | 1.0100 on 04/23/25 | ||
High | 0.3785 on 04/23/25 | 2.74 on 04/29/25 | 1.2400 on 04/29/25 | ||
1-Month | |||||
%Chg | -22.82% since 03/28/25 | -15.11% since 03/28/25 | +25.25% since 03/28/25 | ||
Low | 0.2200 on 04/07/25 | 1.98 on 04/17/25 | 0.8400 on 04/10/25 | ||
High | 0.5200 on 04/02/25 | 3.17 on 03/31/25 | 1.2400 on 04/29/25 | ||
3-Month | |||||
%Chg | -24.20% since 01/29/25 | -37.74% since 01/29/25 | +13.89% since 01/29/25 | ||
Low | 0.2179 on 02/03/25 | 1.98 on 04/17/25 | 0.7200 on 03/14/25 | ||
High | 0.7800 on 02/20/25 | 4.44 on 01/30/25 | 1.6600 on 02/21/25 | ||
6-Month | |||||
%Chg | -84.91% since 10/29/24 | -8.97% since 10/29/24 | -21.66% since 10/29/24 | ||
Low | 0.2179 on 02/03/25 | 1.98 on 04/17/25 | 0.7000 on 12/31/24 | ||
High | 2.3900 on 10/31/24 | 6.28 on 01/17/25 | 2.4400 on 01/03/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 14,670 | 15,784 | 14,120 | ||
Shares Outstanding, K | 41,879 | 5,890 | 11,574 | ||
Annual Sales | 6,770,000 | 15,030,000 | 1,760,000 | ||
Annual Net Income | -53,360,000 | -11,140,000 | -2,180,000 | ||
Last Quarter Sales | 3,150,000 | 3,700,000 | 670,000 | ||
Last Quarter Net Income | -6,590,000 | -2,830,000 | 250,000 | ||
60-Month Beta | -0.56 | 7.31 | 0.95 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.35 on 11/13/24 | -0.28 on 03/31/25 | -0.05 on 11/12/24 | ||
Latest Earnings Date | 05/08/25 | 05/13/25 | 05/09/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |